EUVIMEDEUVIMED entdecken
Crossref

Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9

Philipp Grosche iD, Alec N Flyer iD, Raphael Gattlen, Mei Xu, Andrei A Golosov, Victoria Vera, Stephanie Pickett, Margaret E Brousseau, Rajiv Chopra, Kevin B Clairmont iD, Alexander Koch, Eugene Liu und 5 weitere

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Philipp Grosche und 16 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Biomedical Research, Fabrikstrasse 2, Novartis Campus, 4056, Basel, Switzerland. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Peptides, Cyclic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates plasma low‐density lipoprotein cholesterol (LDL−C) levels by promoting hepatic LDL receptor (LDL−R) degradation. We previously identified and optimized 13‐mer cyclic peptides that bind to a novel, induced‐fit pocket adjacent to the binding interface of PCSK9 and LDL−R and effectively disrupted the PCSK9/LDL−R protein‐protein interaction (PPI) both in vitro and in vivo. However this series of large cyclic peptides required charged groups for function and lacked oral bioavailability in rodents. We describe herein multiple structure‐based modifications to these original peptides to yield truncated, neutral molecules with full PPI function in both biochemical and cellular assays. In parallel, new mRNA‐peptide display screens identified non‐functional 8‐ and 9‐mer compounds which ligand the induced‐fit pocket in a distinct manner. Taken together, these studies indicate multiple directions to reduce the size and complexity of this peptide class toward a true small molecule oral agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9Peptides, CyclicHumansStructure-Activity RelationshipDrug DiscoveryMolecular StructureBinding SitesDose-Response Relationship, DrugProtein BindingReceptors, LDLPCSK9 Inhibitors

Stichwörter der Autor:innen

Cyclic peptideLDL−CLDL−RPCSK9PPI disruptionPeptide structure-based drug design

Substanzen

Proprotein Convertase 9Peptides, CyclicPCSK9 protein, humanReceptors, LDLPCSK9 Inhibitors

Autor:innen und Institutionen

  • Novartis Biomedical Research, Fabrikstrasse 2, Novartis Campus, 4056, Basel, Switzerland.
  • Novartis Biomedical Research, 22 Windsor Street and 181 Massachusetts Avenue, Cambridge, MA, 02139, USA.
  • PeptiDream, Inc., KOL Building, Room 405, 4-6-1 Komaba, Meguro-Ku, Tokyo, 153-8904, Japan.

ORCID-Profile: Philipp Grosche, Alec N Flyer, Kevin B Clairmont

Zitieren

APA

Grosche, P., Flyer, A. N., Gattlen, R., Xu, M., Golosov, A. A., Vera, V., Pickett, S., Brousseau, M. E., Chopra, R., Clairmont, K. B., Koch, A., Liu, E., Reid, P., Perry, L., Yang, L., Yang, Q., & Monovich, L. G. (2024). Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9. ChemMedChem. https://doi.org/10.1002/cmdc.202400208

Vancouver

Grosche P, Flyer AN, Gattlen R, Xu M, Golosov AA, Vera V, et al. Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9. ChemMedChem. 2024. doi:10.1002/cmdc.202400208

BibTeX
@article{Grosche2024,
  author = {Grosche, Philipp and Flyer, Alec N and Gattlen, Raphael and Xu, Mei and Golosov, Andrei A and Vera, Victoria and Pickett, Stephanie and Brousseau, Margaret E and Chopra, Rajiv and Clairmont, Kevin B and Koch, Alexander and Liu, Eugene and Reid, Patrick and Perry, Lauren and Yang, Lihua and Yang, Qing and Monovich, Lauren G},
  title = {Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400208}
}
Kostenlos starten →